Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Celestica, Inc. | CTW0 | Oct 14, 2024 | 59.00 | +2.61 |
CELL IMPACT AB | ICLA | Oct 14, 2024 | 0.01 | +10.98 |
CellaVision | C26 | Oct 14, 2024 | 25.25 | -0.79 |
Cellcom Israel Limited | F5U | Oct 14, 2024 | 3.70 | 0.00 |
Celldex Therapeutics, Inc. | TCE2 | Oct 14, 2024 | 28.60 | +5.93 |
Cellectar Biosciences | NV4 | Oct 14, 2024 | 1.89 | 0.00 |
Cellectis | ZVA | Oct 14, 2024 | 1.79 | -2.40 |
Cellectis S.A. - American Depositary Shares | ZVAA | Oct 14, 2024 | 1.73 | -2.81 |
CELLINK B | 49Z | Oct 14, 2024 | 3.45 | -3.36 |
Cellnex Telecom S.A. | 472 | Oct 14, 2024 | 35.33 | +0.43 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Oct 14, 2024 | 17.00 | +1.19 |
Cellular Goods Plc | 6XS | Oct 14, 2024 | 0.00 | 0.00 |
Celon Pharma SA | 8RP | Oct 14, 2024 | 6.91 | +6.64 |
Celsion Corporation | CBO | Oct 14, 2024 | 0.92 | +1.11 |
Celsius Resources Limited | FX8 | Oct 14, 2024 | 0.01 | 0.00 |
Celtic plc | CCP | Oct 14, 2024 | 1.87 | -3.11 |
Celyad Oncology | 1C0 | Oct 14, 2024 | 0.22 | -0.68 |
Cemat | 1X9 | Oct 14, 2024 | 0.14 | -0.37 |
CEMBRE S.P.A. EO 0,52 | J0L | Oct 14, 2024 | 37.50 | +0.27 |
Cementir Holding N.V. | 3PC | Oct 14, 2024 | 9.39 | -0.11 |
Cementos Pacasmayo S.A.A. American Depositary Shares (Each r | EPCC | Oct 14, 2024 | 5.20 | +0.97 |
Cemex S.A.B. De C.V. | CEXA | Oct 14, 2024 | 5.60 | 0.00 |
Cemex S.A.B. De C.V. CPO | CEXB | Oct 14, 2024 | 0.55 | -0.91 |
Cenergy Holdings | 9CN | Oct 14, 2024 | 9.04 | -0.77 |
Cenit AG | CSH | Oct 14, 2024 | 11.20 | -1.75 |
Cenovus Energy Inc | CXD | Oct 14, 2024 | 16.00 | -0.71 |
Cenovus Energy Inc PRF PERPETUAL CAD - Ser 1 | CXD0 | Oct 14, 2024 | 11.80 | +0.85 |
CENOVUS ENERGY PFD SR.2 | CXD1 | Oct 14, 2024 | 11.70 | 0.00 |
CENOVUS ENERGY PFD SR.5 | CXD2 | Oct 14, 2024 | 14.90 | 0.00 |
CENOVUS ENERGY PFD SR.7 | CXD3 | Oct 14, 2024 | 14.60 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.